Latest filing published 03 Feb 2026 for AdaptHealth Corp..
Filing timeline
BuySaleInsider track record
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Jason A. Clemens: trading record in brief
Jason A. Clemens is a declared insider of AdaptHealth Corp. (finance chief), with filings sourced from SEC (Form 4). Over a trading history stretching from 10 August 2020 to 30 January 2026, the count stands at 18 filings.
Both buying and selling appear: 3 purchases worth €54k, against 1 sale worth €310k. The net balance comes to €256k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 14 share grants.
In size, the median ticket on the buying side is €22k. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 3 February 2026 came the latest disclosure, a share grant in AdaptHealth Corp. The clock since the last published purchase (14 August 2023) now reads 1,183 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jason A. Clemens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 126,899 shares0Common StockSEC:0001104659-26-009919:0
- 125,863 shares0Common StockSEC:0001104659-25-009134:0
- 35,000 shares@ US$9.3553.7% of flowCommon StockSEC:0001104659-24-128040:0
- 128,380 shares0Common StockSEC:0001104659-24-036718:0
- 139,112 shares0Common StockSEC:0001104659-24-011738:0
- 5,893 shares@ US$7.547.2% of flowCommon StockSEC:0001104659-23-109138:0
- 720 shares@ US$14.101.6% of flowCommon StockSEC:0001104659-23-091570:0Canonical exit: 8 Nov 2023 (T+90)
- 5,972 shares@ US$12.8111.8% of flowCommon StockSEC:0001104659-23-081721:0
- 35,971 shares0Common StockSEC:0001104659-23-031879:0
- 624 shares@ US$15.991.6% of flowCommon StockSEC:0001104659-23-028024:0
- 3,606 shares@ US$21.3812.3% of flowCommon StockSEC:0001104659-23-010760:0
- 1,590 shares@ US$15.68994.0% of flowCommon StockSEC:0001104659-22-030059:0Canonical exit: 31 May 2022 (T+90)
- 6,503 shares0Common StockSEC:0001104659-22-025200:0
- 37,670 shares0Common StockSEC:0001104659-22-011413:0
- 1,300 shares@ US$19.76684.1% of flowCommon StockSEC:0001104659-21-145997:0Canonical exit: 1 Mar 2022 (T+90)
- 40,359 shares0Common StockSEC:0001104659-21-125923:0
16 of 16 declarations
